文献速递基础与转化研究组学、生物样本库与精准医学医学人工智能与信息学

纳米图案化微芯片实现细胞外囊泡分子与功能分析监测肿瘤进展和转移

Molecular and functional extracellular vesicle analysis using nanopatterned microchips monitors tumor progression and metastasis.
PubMed 文献 · Sci Transl Med · 2020-01-01

该研究开发了一种基于 colloidal inkjet 打印的纳米图案化微芯片系统,可整合分析肿瘤相关细胞外囊泡(EVs)上 MMP14 的表达与蛋白水解活性。利用癌细胞系和小鼠模型,该平台能检测体外细胞侵袭性并监测体内肿瘤转移。临床血浆分析在训练队列(n=30)中区分年龄匹配对照与导管原位癌、浸润性导管癌或局部转移性乳腺癌的准确率为96.7%,独立验证队列(n=70)为92.9%。

要点

  • 纳米微芯片可同时分析EV上MMP14表达与活性。
  • 该平台可检测体外侵袭性并监测小鼠肿瘤转移。
  • 临床血浆分类乳腺癌分期准确率训练集96.7%、验证集92.9%。

核心结论

  • 纳米图案化微芯片整合分析EV上MMP14表达与蛋白水解活性,有望作为液体活检工具用于癌症检测和肿瘤演进实时监测。

研究设计与样本

  • 开发广义高分辨率胶体喷墨打印方法制造三维纳米图案化器件,构建可整合功能与分子表型分析的肿瘤相关EV纳米芯片平台。
  • 使用癌细胞系和小鼠模型进行体外侵袭性与体内转移监测验证。
  • 分析临床血浆标本,在训练队列(n=30)和独立验证队列(n=70)中评估癌症检测与分类性能。

主要发现

  • 纳米芯片平台可整合分析EV上MMP14的表达和蛋白水解活性,用于检测体外细胞侵袭性并监测体内肿瘤转移。
  • 临床血浆分析可准确分类年龄匹配对照与导管原位癌、浸润性导管癌或局部转移性乳腺癌患者,训练队列(n=30)准确率96.7%,独立验证队列(n=70)准确率92.9%。

关键数值与推荐

  • 训练队列(n=30)分类准确率96.7%,独立验证队列(n=70)分类准确率92.9%。

临床怎么用

  • 该技术经临床验证后,可作为液体活检工具改进癌症诊断,并实时监测患者肿瘤演进以指导个体化治疗。

局限性

  • EV分析的临床相关性仍 largely undetermined,部分源于EV分析的技术挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Longitudinal cancer monitoring is crucial to clinical implementation of precision medicine. There is growing evidence indicating important functions of extracellular vesicles (EVs) in tumor progression and metastasis, including matrix remodeling via transporting matrix metalloproteases (MMPs). However, the clinical relevance of EVs remains largely undetermined, partially owing to challenges in EV analysis. Distinct from existing technologies mostly focused on characterizing molecular constituents of EVs, here we report a nanoengineered lab-on-a-chip system that enables integrative functional and molecular phenotyping of tumor-associated EVs. A generalized, high-resolution colloidal inkjet printing method was developed to allow robust and scalable manufacturing of three-dimensional (3D) nanopatterned devices. With this nanochip platform, we demonstrated integrative analysis of the expression and proteolytic activity of MMP14 on EVs to detect in vitro cell invasiveness and monitor in vivo tumor metastasis, using cancer cell lines and mouse models. Analysis of clinical plasma specimen showed that our technology could be used for cancer detection including accurate classification of age-matched controls and patients with ductal carcinoma in situ, invasive ductal carcinoma, or locally metastatic breast cancer in a training cohort (n = 30, 96.7% accuracy) and an independent validation cohort (n = 70, 92.9% accuracy). With clinical validation, our technology could provide a useful liquid biopsy tool to improve cancer diagnostics and real-time surveillance of tumor evolution in patients to inform personalized therapy.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Zhang P, Wu X, Gardashova G, et al. Molecular and functional extracellular vesicle analysis using nanopatterned microchips monitors tumor progression and metastasis. Sci Transl Med. 2020. PMID: 32522804. doi:10.1126/scitranslmed.aaz2878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。